Healthcare worker access to molnupiravir: A case series

Molnupiravir, an oral antiviral shown to reduce COVID-19 severity, is available in Australia via the Pharmaceutical Benefits Scheme (PBS) for treatment of mild-moderate COVID-19. For people less than 70 years of age it is only available with risk factors for severe disease, hence the majority of hea...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Keeffe, Jessica C., Constable, Meg, Chiang, Janice, Somerville, Margaret, Yerramilli, Arvind, Nolan, Ross, Weeks, Greg, O’Brien, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013897/
https://www.ncbi.nlm.nih.gov/pubmed/36917596
http://dx.doi.org/10.1371/journal.pone.0282695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013897/
https://www.ncbi.nlm.nih.gov/pubmed/36917596
http://dx.doi.org/10.1371/journal.pone.0282695

Ejemplares similares